Literature DB >> 28634943

3D-Dynamic Culture Models of Multiple Myeloma.

Marina Ferrarini1, Nathalie Steimberg2, Jennifer Boniotti2, Angiola Berenzi3, Daniela Belloni4, Giovanna Mazzoleni2, Elisabetta Ferrero5.   

Abstract

3D-dynamic culture models represent an invaluable tool for a better comprehension of tumor biology and drug response, as they accurately re-create/preserve the complex multicellular organization and the dynamic interactions of the parental microenvironment, which can affect tumor fate and drug sensitivity. Hence, development of models that recapitulate tumor within its embedding microenvironment is an imperative need. This is particularly true for multiple myeloma (MM), which survives almost exclusively in the bone marrow (BM). To meet this need, we have previously exploited and validated an innovative 3D-dynamic culture technology, based on the use of the Rotary Cell Culture System (RCCS ™) bioreactor . Here, we describe, step by step, the procedures we have employed to establish two human MM ex vivo models, i.e., the culture of human BM-derived isolated cells and of MM tissues from patients.

Entities:  

Keywords:  3D-dynamic culture; Bioreactor; Microenvironment; Multiple myeloma; Tissue models

Mesh:

Year:  2017        PMID: 28634943     DOI: 10.1007/978-1-4939-7021-6_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.

Authors:  Antonia Reale; Tiffany Khong; Rong Xu; Maoshan Chen; Sridurga Mithraprabhu; Nicholas Bingham; Andrew Spencer; David W Greening
Journal:  Methods Mol Biol       Date:  2021

2.  A 3D-Bioprinted Multiple Myeloma Model.

Authors:  Di Wu; Zongyi Wang; Jun Li; Yan Song; Manuel Everardo Mondragon Perez; Zixuan Wang; Xia Cao; Changliang Cao; Sushila Maharjan; Kenneth C Anderson; Dharminder Chauhan; Yu Shrike Zhang
Journal:  Adv Healthc Mater       Date:  2021-09-23       Impact factor: 11.092

Review 3.  Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.

Authors:  Vincent Roy; Brice Magne; Maude Vaillancourt-Audet; Mathieu Blais; Stéphane Chabaud; Emil Grammond; Léo Piquet; Julie Fradette; Isabelle Laverdière; Véronique J Moulin; Solange Landreville; Lucie Germain; François A Auger; François Gros-Louis; Stéphane Bolduc
Journal:  Biomed Res Int       Date:  2020-04-13       Impact factor: 3.411

Review 4.  3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations.

Authors:  Virginia Guzzeloni; Lorenzo Veschini; Federica Pedica; Elisabetta Ferrero; Marina Ferrarini
Journal:  Antibodies (Basel)       Date:  2022-07-08

5.  Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.

Authors:  Daniela Belloni; Marina Ferrarini; Elisabetta Ferrero; Virginia Guzzeloni; Federica Barbaglio; Paolo Ghia; Cristina Scielzo
Journal:  STAR Protoc       Date:  2022-08-10

Review 6.  From the Clinical Problem to the Basic Research-Co-Culture Models of Osteoblasts and Osteoclasts.

Authors:  Sheng Zhu; Sabrina Ehnert; Marc Rouß; Victor Häussling; Romina H Aspera-Werz; Tao Chen; Andreas K Nussler
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

7.  A worm gel-based 3D model to elucidate the paracrine interaction between multiple myeloma and mesenchymal stem cells.

Authors:  Renza Spelat; Federico Ferro; Paolo Contessotto; Nicholas J Warren; Grazia Marsico; Steven P Armes; Abhay Pandit
Journal:  Mater Today Bio       Date:  2020-01-07

8.  JunB is a key regulator of multiple myeloma bone marrow angiogenesis.

Authors:  Fengjuan Fan; Stefano Malvestiti; Sonia Vallet; Judith Lind; Jose Manuel Garcia-Manteiga; Eugenio Morelli; Qinyue Jiang; Anja Seckinger; Dirk Hose; Hartmut Goldschmidt; Andreas Stadlbauer; Chunyan Sun; Heng Mei; Martin Pecherstorfer; Latifa Bakiri; Erwin F Wagner; Giovanni Tonon; Martin Sattler; Yu Hu; Pierfrancesco Tassone; Dirk Jaeger; Klaus Podar
Journal:  Leukemia       Date:  2021-05-18       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.